Variant report
Variant | esv3379614 |
---|---|
Chromosome Location | chr9:18353302-18355250 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536980601 | chr9:18353331-18353332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554935441 | chr9:18353343-18353344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554725119 | chr9:18353359-18353360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543608971 | chr9:18353360-18353361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148505990 | chr9:18353367-18353368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142843424 | chr9:18353389-18353390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369897871 | chr9:18353393-18353394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs151037553 | chr9:18353409-18353410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141073162 | chr9:18353429-18353430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529638206 | chr9:18353467-18353468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555362977 | chr9:18353472-18353473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548488915 | chr9:18353489-18353490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563401662 | chr9:18353496-18353497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572847227 | chr9:18353507-18353508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539858979 | chr9:18353576-18353577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573509320 | chr9:18353634-18353635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530742167 | chr9:18353661-18353662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552040366 | chr9:18353860-18353861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570311651 | chr9:18353899-18353900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538780956 | chr9:18353919-18353920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547462578 | chr9:18353922-18353923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs56139132 | chr9:18353987-18353988 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs377615874 | chr9:18353999-18354000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536215287 | chr9:18354001-18354002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374941434 | chr9:18354043-18354044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369318387 | chr9:18354046-18354047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs33985764 | chr9:18354047-18354048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs386414574 | chr9:18354056-18354057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188145129 | chr9:18354062-18354063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71333039 | chr9:18354067-18354068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576611545 | chr9:18354077-18354078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537745586 | chr9:18354177-18354178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559233420 | chr9:18354178-18354179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144899377 | chr9:18354185-18354186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181006095 | chr9:18354205-18354206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186416353 | chr9:18354229-18354230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146717428 | chr9:18354330-18354331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574389184 | chr9:18354343-18354344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541423705 | chr9:18354367-18354368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576762894 | chr9:18354394-18354395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191359463 | chr9:18354440-18354441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556332849 | chr9:18354505-18354506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371000830 | chr9:18354524-18354525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530761759 | chr9:18354553-18354554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373297735 | chr9:18354562-18354563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181411363 | chr9:18354577-18354578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552045505 | chr9:18354628-18354629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563965697 | chr9:18354632-18354633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546416114 | chr9:18354675-18354676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140358758 | chr9:18354690-18354691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Ovarian cancer | 19835627 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:18333400-18368200 | Weak transcription | Aorta | Aorta |
2 | chr9:18346600-18362000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:18347600-18360400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr9:18348000-18354400 | Weak transcription | HSMMtube | muscle |
5 | chr9:18348200-18357400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr9:18350400-18356000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr9:18351800-18361600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr9:18352000-18358800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr9:18352800-18353400 | Enhancers | Fetal Heart | heart |
10 | chr9:18352800-18353400 | Weak transcription | Fetal Kidney | kidney |
11 | chr9:18353000-18353400 | Enhancers | A549 | lung |
12 | chr9:18353400-18353600 | Enhancers | Fetal Kidney | kidney |